Virgin Media O2 owners to challenge UK regulator on Netomnia deal
Virgin Media O2's owners plan to challenge the UK's CMA over its opposition to their £2B acquisition of Netomnia, disputing the regulator's concerns about reduced competition. Nexfibre, a JV of Liberty Global, Telefonica, and InfraVia, argues the CMA's report is flawed and that the deal would bring significant investment.
How this was made
The 30-second read
Why it matters
The regulatory hurdle introduces uncertainty around deal completion, likely weighing on the share prices of the owners and the broader UK fibre market.
Market read
Regulatory opposition to a large‑scale fibre acquisition creates short‑term risk for the involved owners and may affect sentiment in the UK telecom infrastructure sector.
What to watch
Potential for alternative bidders or revised deal terms that could mitigate regulatory concerns.
Background
Nexfibre, a joint venture of Liberty Global, Telefonica and InfraVia, agreed to buy Netomnia for £2 bn. The CMA opposed the deal, preferring CityFibre as a buyer. Nexfibre announced it will not offer remedies and will challenge the regulator's reasoning.
Ticker impact
Liberty Global, co-owner of Nexfibre, is involved in the £2 bn Netomnia acquisition that is being challenged by the CMA.
likely downside as investors price in potential deal disruption
The CMA opposition is a material hurdle for a large‑scale fibre acquisition; market participants typically react negatively to regulatory setbacks.
Market effects
UK fibre infrastructure sector may see heightened regulatory scrutiny, affecting other players like CityFibre.
UK telecom and infrastructure stocks could experience short‑term volatility.
Limited to European telecom and infrastructure investors; minimal direct impact on broader markets.
Counterpoint
If the CMA ultimately approves the deal, the initial challenge could be priced out, offering a buying opportunity.
Key entities
- CompanyLiberty Global
Co-owner of Nexfibre, US‑listed ADR LBTYA.
- CompanyTelefonica
Co-owner of Nexfibre, US‑listed ADR TEF.
- RegulatorCMA
UK Competition and Markets Authority opposing the acquisition.
